NCT02088775View on ClinicalTrials.gov

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 8, 2016

Study Completion Date

July 30, 2021

Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct CancerRecurrent Adult Primary Liver CancerRecurrent Extrahepatic Bile Duct CancerStage D Adult Primary Liver Cancer (BCLC)Unspecified Adult Solid Tumor, Protocol Specific
Interventions
PROCEDURE

PET scan

Undergo PET-CT scan

PROCEDURE

CT Scan

Undergo PET-CT scan

PROCEDURE

hepatic artery embolization

Undergo standard radioembolization

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER

NCT02088775 - PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer | Biotech Hunter | Biotech Hunter